Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects

Condition:   HER2-positive Recurrent / Metastatic Breast Cancer Interventions:   Drug: pyrotinib tablet;   Drug: Montmorillonite Power;   Drug: Loperamide Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting

Source: ClinicalTrials.gov - February 23, 2022 Category: Research Source Type: clinical trials